Skip to main content
. 2013 Jan 23;13:29. doi: 10.1186/1471-2407-13-29

Table 1.

Percentage of H-460 cells in late or early apoptosis at the end of treatment period either with doxorubicin or P276-00 alone or in the combination of doxorubicin followed by P276-00

Treatment group
Percentage of cells
  Live cells Annexin +ve Annexin + PI PI +ve
Control
90.5
3
4
2.3
Doxorubicin ( 100 nM)
60
30.4
8.6
1
P276-00 (1200 nM)
53
38.5
8.2
0.3
Doxorubicin> P276-00 14.1 50.2 34.3 2